Actively Recruiting
A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma
Led by Amydis Inc. · Updated on 2024-07-30
50
Participants Needed
3
Research Sites
60 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this research study is to assess the ability of AMDX- 2011P to identify amyloid deposits in the retina of participants with Primary Open Angle Glaucoma (POAG).
CONDITIONS
Official Title
A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of primary open angle glaucoma in both eyes
- Able to fixate
- Glaucomatous optic nerve damage in both eyes, confirmed by an eye exam
You will not qualify if you...
- Unable to read or write
- Ocular media not clear enough to get good quality images
- Any eye disease other than glaucoma present in the study eye (cataracts allowed)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Associated Retina Consultants
Phoenix, Arizona, United States, 85020
Actively Recruiting
2
Global Research Management
Glendale, California, United States, 91204
Actively Recruiting
3
Eye Research Foundation
Newport Beach, California, United States, 92663
Actively Recruiting
Research Team
J
Joyce Simpauco
CONTACT
D
David Bingaman
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here